Lexicon Pharmaceuticals
LXRX
#7142
Rank
โ‚น45.70 B
Marketcap
โ‚น125.77
Share price
-1.41%
Change (1 day)
128.49%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น5.22 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's total debt is โ‚น5.22 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Lexicon Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น9.29 B5.32%
2023-12-31โ‚น8.82 B92.97%
2022-12-31โ‚น4.57 B2597.41%
2021-12-31โ‚น0.16 B-81.89%
2020-12-31โ‚น0.93 B-94.65%
2019-12-31โ‚น17.52 B2.29%
2018-12-31โ‚น17.13 B9.21%
2017-12-31โ‚น15.68 B127.54%
2016-12-31โ‚น6.89 B0.78%
2015-12-31โ‚น6.84 B0.25%
2014-12-31โ‚น6.82 B404.88%
2013-12-31โ‚น1.35 B5.26%
2012-12-31โ‚น1.28 B-2.5%
2011-12-31โ‚น1.31 B3.18%
2010-12-31โ‚น1.27 B-58.92%
2009-12-31โ‚น3.10 B112%
2008-12-31โ‚น1.46 B19.03%
2007-12-31โ‚น1.23 B-13.63%
2006-12-31โ‚น1.42 B-14.24%
2005-12-31โ‚น1.66 B2%
2004-12-31โ‚น1.62 B-36.47%
2003-12-31โ‚น2.56 B1237.38%
2002-12-31โ‚น0.19 B
2000-12-31โ‚น0.13 B-36.05%
1999-12-31โ‚น0.20 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
โ‚น49.58 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น243.05 B 4,552.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น3.03 B-41.82%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น54.28 B 939.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น3.205 T 61,258.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น27.56 B 427.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น231.41 B 4,329.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น40.51 B 675.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น30.27 B 479.51%๐Ÿ‡บ๐Ÿ‡ธ USA